BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32537923)

  • 21. Sporadic hypophosphatemic osteomalacia combined with psoriasis: A rare case report and a brief review of the literature.
    Li Y; Chen X; Wang B; Liu X; Hou S
    Int J Rheum Dis; 2023 May; 26(5):968-972. PubMed ID: 36625293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
    de Jongh RT; Vervloet MG; Bravenboer N; Heijboer AC; den Heijer M; Lips P
    Ned Tijdschr Geneeskd; 2013; 157(28):A5908. PubMed ID: 23841927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor induced osteomalacia.
    Filipová L; Lazúrová I
    Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor-induced hypophosphatemic osteomalacia].
    Ito N; Fukukmoto S
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.
    Ungari C; Rocchi G; Rinna C; Agrillo A; Lattanzi A; Pagnoni M
    J Craniofac Surg; 2004 May; 15(3):523-7. PubMed ID: 15111823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypophosphataemia-inducing mesenchymal tumour in the foot.
    Bauer C; Brücker R; Bützberger S; Schmid C
    BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22778109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reduced bone density and bone pain :osteomalacia with hypophospatemia and hypophosphaturia].
    Findeisen HM; Auernhammer CJ; Parhofer KG; Herrmann KA; la Fougere C; Weiler C; Bartl R; Koch E
    Internist (Berl); 2009 Dec; 50(12):1402-7. PubMed ID: 19756443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour-induced osteomalacia due to residual benign glomangioma.
    Barai R; Tsang T; Cespedes L
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36357106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
    Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.
    Kurien R; Rupa V; Thomas M
    Eur Arch Otorhinolaryngol; 2019 Jun; 276(6):1677-1684. PubMed ID: 30879192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
    Alonso G; Varsavsky M
    Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-induced osteomalacia.
    Jan de Beur SM
    JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
    Elderman JH; Wabbijn M; de Jongh F
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27118742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?
    Latifyan SB; Vanhaeverbeek M; Klastersky J
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
    Ito N; Shimizu Y; Suzuki H; Saito T; Okamoto T; Hori M; Akahane M; Fukumoto S; Fujita T
    J Intern Med; 2010 Oct; 268(4):390-4. PubMed ID: 20698924
    [No Abstract]   [Full Text] [Related]  

  • 38. A case of hyperparathyroidism secondary to tumor-induced osteomalacia.
    Yang Y; Jin P; Zhang S; Chen K; He H; Mo Z; Yuan J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1937-1944. PubMed ID: 38448388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic osteomalacia from pterygopalatine fossa mass.
    Savage CR; Zimmer LA
    J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypophosphatemic osteomalacia].
    Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
    Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.